EGFR and non-small cell lung carcinoma: The most EGCG-responsive NSCLC, in terms of both signaling pathway activation and cell migration, is, however, the HCC827 cell line in which all analyzed EGFR downstream pathways, from mTOR to MAPK38, are suppressed.